Lumexa Imaging (NASDAQ:LMRI) Hits New 12-Month Low – What’s Next?

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) reached a new 52-week low during trading on Thursday . The stock traded as low as $7.14 and last traded at $7.6350, with a volume of 292131 shares traded. The stock had previously closed at $8.05.

Analyst Ratings Changes

Several research analysts have commented on LMRI shares. Barclays decreased their target price on shares of Lumexa Imaging from $23.00 to $15.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Raymond James Financial upgraded shares of Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 target price for the company in a research report on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Strong Buy” and an average target price of $19.00.

Lumexa Imaging Trading Down 10.4%

The company has a 50 day moving average of $10.67.

Institutional Trading of Lumexa Imaging

A number of institutional investors have recently made changes to their positions in LMRI. Assetmark Inc. acquired a new stake in shares of Lumexa Imaging in the 4th quarter worth approximately $36,000. Strs Ohio acquired a new stake in shares of Lumexa Imaging in the 1st quarter worth approximately $38,000. PNC Financial Services Group Inc. acquired a new stake in shares of Lumexa Imaging in the 1st quarter worth approximately $63,000. State of Wyoming acquired a new stake in shares of Lumexa Imaging in the 1st quarter worth approximately $91,000. Finally, Barclays PLC acquired a new stake in shares of Lumexa Imaging in the 4th quarter worth approximately $133,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).